Keratoconjunctivitis Sicca
📧 Sign up to get email alerts when something new happens for Keratoconjunctivitis Sicca.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-01-15EMA Authorised: Ikervis (ciclosporin) — Santen Oy
The EMA authorised Ikervis (ciclosporin) for corneal diseases. The marketing authorization holder is Santen Oy, with a decision date of 27 F…
-
EMA approval · 2025-04-24EMA Authorised: Vevizye (ciclosporin) — Laboratoires Théa
The EMA has authorised Vevizye, an ophthalmic ciclosporin product from Laboratoires Théa, for keratoconjunctivitis sicca (dry eye disease).